2018–2019 Drug Updates in Hematologic Malignancies

Lauren Held, PharmD, BCOP, updated attendees on the FDA-approved therapies for initial or expanded indications for hematologic malignancies across the past year, as well as their supporting clinical trial data and best practices for safe and effective dosing and administration, drug monitoring, and...

Descripción completa

Detalles Bibliográficos
Autor principal: Held, Lauren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857325/
https://www.ncbi.nlm.nih.gov/pubmed/33598320
http://dx.doi.org/10.6004/jadpro.2020.11.3.7
_version_ 1783646425947570176
author Held, Lauren
author_facet Held, Lauren
author_sort Held, Lauren
collection PubMed
description Lauren Held, PharmD, BCOP, updated attendees on the FDA-approved therapies for initial or expanded indications for hematologic malignancies across the past year, as well as their supporting clinical trial data and best practices for safe and effective dosing and administration, drug monitoring, and adverse event management.
format Online
Article
Text
id pubmed-7857325
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-78573252021-02-16 2018–2019 Drug Updates in Hematologic Malignancies Held, Lauren J Adv Pract Oncol Meeting Reports Lauren Held, PharmD, BCOP, updated attendees on the FDA-approved therapies for initial or expanded indications for hematologic malignancies across the past year, as well as their supporting clinical trial data and best practices for safe and effective dosing and administration, drug monitoring, and adverse event management. Harborside Press LLC 2020-04 2020-04-01 /pmc/articles/PMC7857325/ /pubmed/33598320 http://dx.doi.org/10.6004/jadpro.2020.11.3.7 Text en © 2020 Harborside™ http://creativecommons.org/licenses/by-nc-nd/3.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Held, Lauren
2018–2019 Drug Updates in Hematologic Malignancies
title 2018–2019 Drug Updates in Hematologic Malignancies
title_full 2018–2019 Drug Updates in Hematologic Malignancies
title_fullStr 2018–2019 Drug Updates in Hematologic Malignancies
title_full_unstemmed 2018–2019 Drug Updates in Hematologic Malignancies
title_short 2018–2019 Drug Updates in Hematologic Malignancies
title_sort 2018–2019 drug updates in hematologic malignancies
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857325/
https://www.ncbi.nlm.nih.gov/pubmed/33598320
http://dx.doi.org/10.6004/jadpro.2020.11.3.7
work_keys_str_mv AT heldlauren 20182019drugupdatesinhematologicmalignancies

Ejemplares similares